Literature DB >> 15117318

Insights into the phosphoregulation of beta-secretase sorting signal by the VHS domain of GGA1.

Tomoo Shiba1, Satoshi Kametaka, Masato Kawasaki, Masahiro Shibata, Satoshi Waguri, Yasuo Uchiyama, Soichi Wakatsuki.   

Abstract

BACE (beta-site amyloid precursor protein cleaving enzyme, beta-secretase) is a type-I membrane protein which functions as an aspartic protease in the production of beta-amyloid peptide, a causative agent of Alzheimer's disease. Its cytoplasmic tail has a characteristic acidic-cluster dileucine motif recognized by the VHS domain of adaptor proteins, GGAs (Golgi-localizing, gamma-adaptin ear homology domain, ARF-interacting). Here we show that BACE is colocalized with GGAs in the trans-Golgi network and peripheral structures, and phosphorylation of a serine residue in the cytoplasmic tail enhances interaction with the VHS domain of GGA1 by about threefold. The X-ray crystal structure of the complex between the GGA1-VHS domain and the BACE C-terminal peptide illustrates a similar recognition mechanism as mannose 6-phosphate receptors except that a glutamine residue closes in to fill the gap created by the shorter BACE peptide. The serine and lysine of the BACE peptide point their side chains towards the solvent. However, phosphorylation of the serine affects the lysine side chain and the peptide backbone, resulting in one additional hydrogen bond and a stronger electrostatic interaction with the VHS domain, hence the reversible increase in affinity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117318     DOI: 10.1111/j.1600-0854.2004.00188.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  30 in total

Review 1.  Inhibition of BACE1 for therapeutic use in Alzheimer's disease.

Authors:  Xiaoyang Luo; Riqiang Yan
Journal:  Int J Clin Exp Pathol       Date:  2010-07-08

Review 2.  The study of Golgi apparatus in Alzheimer's disease.

Authors:  Zhiping Hu; Liuwang Zeng; Zhiling Huang; Jie Zhang; Ting Li
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

3.  Ubiquitin regulates GGA3-mediated degradation of BACE1.

Authors:  Eugene L Kang; Andrew N Cameron; Fabrizio Piazza; Kendall R Walker; Giuseppina Tesco
Journal:  J Biol Chem       Date:  2010-05-18       Impact factor: 5.157

4.  Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts.

Authors:  Kulandaivelu S Vetrivel; Xavier Meckler; Ying Chen; Phuong D Nguyen; Nabil G Seidah; Robert Vassar; Philip C Wong; Masaki Fukata; Maria Z Kounnas; Gopal Thinakaran
Journal:  J Biol Chem       Date:  2008-12-12       Impact factor: 5.157

Review 5.  β-Secretase: its biology as a therapeutic target in diseases.

Authors:  Haibo Wang; Rena Li; Yong Shen
Journal:  Trends Pharmacol Sci       Date:  2013-02-27       Impact factor: 14.819

6.  The clathrin adaptor Gga2p is a phosphatidylinositol 4-phosphate effector at the Golgi exit.

Authors:  Lars Demmel; Maike Gravert; Ebru Ercan; Bianca Habermann; Thomas Müller-Reichert; Viktoria Kukhtina; Volker Haucke; Thorsten Baust; Marc Sohrmann; Yannis Kalaidzidis; Christian Klose; Mike Beck; Matthias Peter; Christiane Walch-Solimena
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

7.  Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated.

Authors:  Sandra I Vieira; Sandra Rebelo; Hermann Esselmann; Jens Wiltfang; James Lah; Rachel Lane; Scott A Small; Sam Gandy; Edgar F da Cruz E Silva; Odete Ab da Cruz E Silva
Journal:  Mol Neurodegener       Date:  2010-10-11       Impact factor: 14.195

Review 8.  Structure-activity relationship of memapsin 2: implications on physiological functions and Alzheimer's disease.

Authors:  Xiaoman Li; Lin Hong; Kathleen Coughlan; Liang Wang; Liu Cao; Jordan Tang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2013-05-15       Impact factor: 3.848

Review 9.  BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis.

Authors:  Neville Marks; Martin J Berg
Journal:  Neurochem Res       Date:  2009-09-17       Impact factor: 3.996

10.  The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.

Authors:  S L Cole; R Vassar
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.